CCIT-DK: National Center for Cancer Immune Therapy
@CCITdk
Followers
449
Following
495
Media
72
Statuses
243
Bridging the gap between discovery and clinical implementation in #cancer #immunotherapy #immunooncology at @HerlevGentofte Copenhagen. SoMe manager @doniamarco
Capital Region, Denmark
Joined April 2018
@CCITdk is happy to support the candidacy of Professor @ulassen to this important post at ESMO @myESMO.
I am pleased and proud to be a candidate running in the election for the position of Nomination Committee Member for ESMO ESMO - @myESMO @Rigshospitalet @OECI_EEIG @ASCO .
0
0
0
RT @DoniaMarco: Acquired resistance to Cancer Immunotherapy.Free at ➡️ Metastatic cancers can be cured.➡️ Pts who i….
0
1
0
RT @jitcancer: New #JITC article: Arginase-1-specific T cells target and modulate tumor-associated macrophages @mar….
0
3
0
🎉Cell Therapy Milestone.👍This week, a patient with melanoma received the first non-viral CRISPR-edited TIL infusion product at @CCITdk . Congrats to Cell Therapy team @ozcan_met: from preclinical to GMP grade
0
2
3
RT @esmo_iotech: 📢 Check out this special case report by Monberg, Svane & colleagues @CCITdk @helsinkiuni @Rigshospitalet 🇩🇰🇫🇮. 💉Combined….
esmoiotech.org
Despite significant advancements in the treatment of malignant melanoma, metastatic mucosal melanoma remains a therapeutic challenge due to its complex pathogenesis, distinct pathological character...
0
2
0
📣 PhD course "Cancer Immunology and Immunotherapy", 4th edition.📃 Course Description and registration 👉▶WHEN: 07-11/04/2025 (mon-fri).▶WHERE: Copenhagen Area, Denmark.📩 Full program available soon! Previous edition at
0
1
2
📢The Copenhagen Symposium on T Cell Therapy and Cellular Engineering (CATC) 2024. ⏰ 24-25 September 2024.📍 Greater Copenhagen, Denmark. More at.
catc.dtu.dk
0
0
2
RT @holmstrom_mo: New publication on #MPNsm from @CCITdk published in @BrJHaem: Peripheral blood lymphocytes (PBL) from patients with CALR….
onlinelibrary.wiley.com
T cells (green) and NK cells (purple) from patients with CALR exon 9 mutant myeloproliferative neoplasms display increased expression of LAP and GARP on their cell membrane compared with patients...
0
3
0
📣 Webinar "Adoptive cell immunotherapies for cancer".SN Oncology Webinar Series on 14 May at 4 pm CEST by @SpringerNature .👉 Free registration at: 👩🔬 Speaker: Inge Marie Svane, Director of @CCITdk .👨🎓 Chair: Luca Danelli, Senior Editor @NatureComms.
cassyni.com
In this webinar, our panelists will discuss recent developments and challenges for adoptive cell therapies for cancer treatment. Our spea...
0
2
8
RT @VHIO: 💬 Fantastic keynote lecture by Dr. Inge Marie Svane from @CCITdk on TIL therapies at VHIO under the framework of #PragamTIL Annua….
0
5
0
RT @DoniaMarco: Despite manufacturing costs ~67 000 €, academic TIL therapy for patients with #melanoma is both cost-saving and cost-effect….
0
5
0
RT @marper2323: Excited to share our latest article on @jitcancer, where we show that a TGFβ-based immune modulatory vaccine can both direc….
0
4
0
RT @jitcancer: New #JITC review: Biomarkers for response to TIL therapy: a comprehensive review @Vic_albarran @pbal….
0
23
0
📣 The Neoantigen Based Cancer Vaccine Pipeline at Dana Farber Cancer Institute.👨⚕️ by Derin Keskin 🕰 March 8th 2024 at 9.15.📍 Auditorium H2, Herlev Hospital, DK.💻Online at ‼️Join this seminar, No registration required‼️
0
0
2
🔬 Murine Models for Cancer Immunotherapy, an analysis of tumor microenvironment (TME) compositions. 🐭 Insights into comparative roles of the Lymphoid, Myeloid, and Stromal cell compartments of these models from the TSMI group here in @CCITdk .More at 👉
frontiersin.org
Murine syngeneic tumor models have been used extensively for cancer research for several decades and have been instrumental in driving the discovery and deve...
1
0
3
RT @DoniaMarco: Harnessing neoantigen-specific T cells for precision cancer immunotherapy.👉 @NatRevClinOncol, Jan 2024, free access link at….
0
15
0
RT @mark_wagon: Published today! Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated f….
frontiersin.org
Murine syngeneic tumor models have been used extensively for cancer research for several decades and have been instrumental in driving the discovery and deve...
0
1
0
RT @DoniaMarco: #Postdoc position in Cancer #Immunotherapy.👉 You get all at once:.1️⃣ Exciting project in the most….
0
7
0
RT @DoniaMarco: PD-L1 status to select for ipilimumab+nivolumab in #melanoma.👉(Eur J Cancer). ✅ PD-L1≥1%: same outc….
0
24
0
Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line. ✅Free access at @natrevdrugdisc👇.(open access provided for a few days). 📖Read about our current efforts at @CCITdk to make this life-saving treatment affordable and accessible.
0
3
11